Induced pluripotent stem cell technology: a decade of progress.

Shi, Yanhong, Inoue, Haruhisa, Wu, Joseph C., Yamanaka, Shinya·2017·Nature Reviews Drug Discovery

Cited by (1,001)

Items 501–600 of 1,001

  1. Genome-edited adult stem cells: Next-generation advanced therapy medicinal products
    Karim Benabdellah, Sabina Sánchez-Hernández, Araceli Aguilar-González, Noelia Maldonado‐Pérez, Alejandra Gutiérrez-Guerrero, Marina Cortijo-Gutierréz, Iris Ramos-Hernández, María Tristán‐Manzano, Pablo Galindo‐Moreno, Concha Herrera et al. · 2020 · Stem Cells Translational Medicine
  2. Neural In Vitro Models for Studying Substances Acting on the Central Nervous System
    Ellen Fritsche, Julia Tigges, Julia Hartmann, Julia Kapr, Melania Maria Serafini, Barbara Viviani · 2020 · Handbook of experimental pharmacology
  3. Induced pluripotent stem cell technology for spinal cord injury: a promising alternative therapy
    Pingping Shen, Bin Wang, Yu Li · 2021 · Neural Regeneration Research
  4. Comparison of growth kinetics between static and dynamic cultures of human induced pluripotent stem cells
    Yuma Kato, Mee‐Hae Kim, Masahiro Kino‐oka · 2018 · Journal of Bioscience and Bioengineering
  5. Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder‐Free Reprogramming System
    Seonmi Park, Gustavo Mostoslavsky · 2018 · Current Protocols in Stem Cell Biology
  6. Synaptic Microcircuit Modeling with 3D Cocultures of Astrocytes and Neurons from Human Pluripotent Stem Cells
    Caroline Cvetkovic, Nupur Basu, Robert Krencik · 2018 · Journal of Visualized Experiments
  7. Mesenchymal stem cell-derived extracellular vesicles for cell-free therapy of ocular diseases
    Xiaoling Liu, Liang Hu, Fei Liu · 2022 · Extracellular Vesicles and Circulating Nucleic Acids
  8. Unlocking the potential of low-molecular-weight (Poly)phenol metabolites: Protectors at the blood-brain barrier frontier
    Daniela Marques, Diogo Moura-Louro, Inês P. Silva, Sara Matos, Cláudia Nunes dos Santos, Inês Figueira · 2024 · Neurochemistry International
  9. Model-guided design of microRNA-based gene circuits supports precise dosage of transgenic cargoes into diverse primary cells
    Kasey S. Love, Christopher P. Johnstone, Emma L. Peterman, Stephanie A. Gaglione, Michael E. Birnbaum, Kate E. Galloway · 2024 · Cell Systems
  10. Reconstruction of endocrine subtype-complete human pluripotent stem cell-derived islets with capacity for hypoglycemia protection in vivo
    Gaofan Meng, Jiabin Gu, Soon Yi Liew, Jingxiao Cao, Zhihui Wang, Chunyu Ma, Zhenzhen Fu, Hongwen Zhou, Jinlin Wang, Shusen Wang et al. · 2025 · Cell stem cell
  11. Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea
    Vivien C. Abad, Christian Guilleminault · 2018 · Expert Review of Respiratory Medicine
  12. Transplantation of fat tissues and iPSC-derived energy expenditure adipocytes to counteract obesity-driven metabolic disorders: Current strategies and future perspectives
    Vincent Dani, Xi Yao, Christian Dani · 2021 · Reviews in Endocrine and Metabolic Disorders
  13. An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
    L. Hsu, Chao-Lin Liu, Ming-Ling Kuo, Chia-Ning Shen, Chia-Rui Shen · 2021 · Biomedicines
  14. Electrophysiological Properties of Induced Pluripotent Stem Cell-Derived Midbrain Dopaminergic Neurons Correlate With Expression of Tyrosine Hydroxylase
    Aleksandar Raković, Dorothea Voß, Franca Vulinović, Britta Meier, Ann-Katrin Hellberg, Carla Nau, Christine Klein, Enrico Leipold · 2022 · Frontiers in Cellular Neuroscience
  15. Fabrication of Polymer/Graphene Biocomposites for Tissue Engineering
    João Meneses, Tom van de Kemp, Raquel Costa‐Almeida, Rúben F. Pereira, Fernão Domingos Magalhães, Miguel Dias Castilho, Artur M. Pinto · 2022 · Polymers
  16. Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models
    Marika Quadri, Alessandra Marconi, Simran Kaur Sandhu, Alexi Kiss, Tatiana Efimova, Elisabetta Palazzo · 2022 · Frontiers in Medicine
  17. Dental Pulp-Derived Stem Cells Reduce Inflammation, Accelerate Wound Healing and Mediate M2 Polarization of Myeloid Cells
    Sarah Anderson, Prateeksha Prateeksha, Hiranmoy Das · 2022 · Biomedicines
  18. Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments
    Annie C. Bowles, Angela C. Jimenez, Hazel Y. Stevens, David A. Frey Rubio, Linda E. Kippner, Carolyn Yeago, Krishnendu Roy · 2023 · Bone Reports
  19. Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
    Jing‐Jun Zhou, Baiping Cui, Xiaochen Wang, Hongkun Wang, Junnan Zheng, Fengfeng Guo, Yaxun Sun, Hangping Fan, Jiaxi Shen, Jun Su et al. · 2023 · Stem Cell Research & Therapy
  20. Engineered Vasculature for Cancer Research and Regenerative Medicine
    Huu Tuan Nguyen, Arne Peirsman, Zuzana Tirpáková, Kalpana Mandal, Florian Vanlauwe, Surjendu Maity, Satoru Kawakita, Danial Khorsandi, Rondinelli Donizetti Herculano, Christian Umemura et al. · 2023 · Micromachines
  21. Stem cell therapy with CRISPR/Cas9-mediated MALAT1 delivery modulates miR-142 and rescues wound healing in rats with age-associated diabetic foot ulcers
    Rongfeng Shi, Cong Chen, Suming Zhao, Hongxin Yuan, Jianmei Zhao, Hui Zhao · 2023 · Archives of Gerontology and Geriatrics
  22. From development to future prospects: The adipose tissue & adipose tissue organoids
    Ezgi Bulut Okumuş, Özüm Begüm Böke, Selinay Şenkal, Ayşegül Doğan · 2024 · Life Sciences
  23. Characterization of companion animal pluripotent stem cells
    Yasmin Z. Paterson, Christiane Kafarnik, Deborah Jane Guest · 2017 · Cytometry Part A
  24. Turning omics data into therapeutic insights
    Amanda J. Kedaigle, Ernest Fraenkel · 2018 · Current Opinion in Pharmacology
  25. Ectopic hTERT expression facilitates reprograming of fibroblasts derived from patients with Werner syndrome as a WS cellular model
    Shuyan Wang, Zhongfeng Liu, Yanxia Ye, Bingnan Li, Tiantian Liu, Weiqi Zhang, Guang‐Hui Liu, Y.Alex Zhang, Jing Tao Qu, Dawei Xu et al. · 2018 · Cell Death and Disease
  26. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles
    Megan Yamoah, Maryam Moshref, Janhavi S Sharma, Wei Chun Chen, Hannah A. Ledford, Jeong Han Lee, Karen Chavez, Wenying Wang, Javier E. López, Deborah K. Lieu et al. · 2018 · International Journal of Nanomedicine
  27. Recent advances in target identification of bioactive natural products
    Minoru Yoshida · 2018 · Bioscience Biotechnology and Biochemistry
  28. Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer’s disease using patient iPSC-derived neurons
    Pei-Chun Wu, Ming‐Ji Fann, Tu Thanh Tran, Shu-Cian Chen, Tania Devina, Irene Han-Juo Cheng, Cheng‐Chang Lien, Lung‐Sen Kao, Shuu‐Jiun Wang, Jong‐Ling Fuh et al. · 2019 · Scientific Reports
  29. Potential of transposon-mediated cellular reprogramming towards cell-based therapies
    Dharmendra Kumar, Taruna Anand, Thirumala Rao Talluri, Wilfried A. Kues · 2020 · World Journal of Stem Cells
  30. Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy
    Bruno Sterlini, Floriana Fruscione, Sımona Baldassari, Fabio Benfenati, Federico Zara, Anna Corradi · 2020 · International Journal of Molecular Sciences
  31. You-on-a-chip’ for precision medicine
    Low, Lucie A., Tagle, Danilo A. · 2018 · Expert Review of Precision Medicine and Drug Development
  32. Genetic, clinical, molecular, and pathogenic aspects of the South Asian–specific polymorphic MYBPC3Δ25bp variant
    Mohammed Arif, Pooneh Nabavizadeh, Taejeong Song, Darshini A. Desai, Rohit R. Singh, Sholeh Bazrafshan, Mohit Kumar, Yigang Wang, Russell Gilbert, Perundurai Subramaniam Dhandapany et al. · 2020 · Biophysical Reviews
  33. Molecular Mechanisms behind Inherited Neurodegeneration of the Optic Nerve
    Alessandra Maresca, Valério Carelli · 2021 · Biomolecules
  34. Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications
    Wei Sheng Siew, Yin-Quan Tang, Chee Kei Kong, Bey Hing Goh, Serena Zacchigna, Kamal Dua, Dinesh Kumar Chellappan, Acharaporn Duangjai, Surasak Saokaew, Pochamana Phisalprapa et al. · 2021 · International Journal of Molecular Sciences
  35. Non-human primate pluripotent stem cells for the preclinical testing of regenerative therapies
    Ignacio Rodríguez-Polo, Rüdiger Behr · 2022 · Neural Regeneration Research
  36. The universal stem cell
    Peter J. Quesenberry, Sicheng Wen, Laura R. Goldberg, Mark S. Dooner · 2022 · Leukemia
  37. Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis
    Maria Raquel Moita, Marta M. Silva, Cláudia Diniz, Margarida Serra, Rene Hoet, Ana Barbas, Daniel F. Simão · 2022 · Frontiers in Cardiovascular Medicine
  38. Gene editing with ‘pencil’ rather than ‘scissors’ in human pluripotent stem cells
    Ju-Chan Park, Mihn Jeong Park, Seung-Yeon Lee, Dayeon Kim, Keun-Tae Kim, Hyeon‐Ki Jang, Hyuk‐Jin Cha · 2023 · Stem Cell Research & Therapy
  39. Engineering Innervated Musculoskeletal Tissues for Regenerative Orthopedics and Disease Modeling
    Zhilong Zhou, Jun Liu, Tiandi Xiong, Yuwei Liu, Rocky S. Tuan, Zhong Alan Li · 2024 · Small
  40. Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
    Thomas L. Maurissen, Masahide Kawatou, Víctor López-Dávila, Kenji Minatoya, Jun K. Yamashita, Knut Woltjen · 2024 · Scientific Reports
  41. Microprinted Stem Cell Niches Reveal Compounding Effect of Colony Size on Stromal Cells‐Mediated Neural Differentiation
    Ramila Joshi, Pradip Shahi Thakuri, James C. Buchanan, Jun Li, Hossein Tavana · 2017 · Advanced Healthcare Materials
  42. Multiparametric Assays for Accelerating Early Drug Discovery
    Alexander Herholt, Sabrina Galinski, Philipp Emanuel Geyer, Moritz J. Rossner, Michael C. Wehr · 2020 · Trends in Pharmacological Sciences
  43. Animal Model Contributions to Congenital Metabolic Disease
    Corinna A. Moro, Wendy Hanna‐Rose · 2020 · Advances in experimental medicine and biology
  44. An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation
    Marion, William, Steffen Boettcher, Ruiz-Torres, Sonya, Lummertz da Rocha, Edroaldo, Lundin, Vanessa, Morris, Vivian, Stephanie S. Chou, Zhao, Anna M, Kubaczka, Caroline, Aumais, Olivia et al. · 2020 · PubMed Central
  45. Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature
    Thomas L. Maurissen, Georgios Pavlou, Colette Andrea Bichsel, Roberto Villaseñor, Roger Dale Kamm, Héloïse Ragelle · 2022 · Journal of Personalized Medicine
  46. Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine
    Kaoru Mitsui, Kanako Ide, Tomoyuki Takahashi, Ken-ichiro Kosai · 2017 · Molecular Therapy — Methods & Clinical Development
  47. Differentiation of human airway-organoids from induced pluripotent stem cells (iPSCs)
    Ruobing Wang, Katherine B. McCauley, Darrell N. Kotton, Finn J Hawkins · 2020 · Methods in cell biology
  48. Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity
    Maximilian Naujock, Anna Speidel, Sandra Elisabeth Fischer, Valeria Kizner, Cornelia Dorner‐Ciossek, Frank Gillardon · 2020 · Stem Cells and Development
  49. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective
    Mohamed M. Bekhite, Paul Christian Schulze · 2021 · Cells
  50. Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors
    Ju-Chan Park, Jumee Kim, Hyeon‐Ki Jang, Seungyeon Lee, Keun-Tae Kim, Eun‐Ji Kwon, Seokwoo Park, Hyun Sik Lee, Hyewon Choi, Seung‐Yeol Park et al. · 2022 · Biomaterials
  51. Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders
    Mandeep Kumar, T. P. Nhung Nguyen, Marco Milanese, Giambattista Bonanno · 2022 · Biomolecules
  52. Using MS induced pluripotent stem cells to investigate MS aetiology
    Alastair J. Fortune, Jessica L. Fletcher, Nicholas B. Blackburn, Kaylene M. Young · 2022 · Multiple Sclerosis and Related Disorders
  53. Dental applications of induced pluripotent stem cells and their derivatives
    Pan Gao, Shan Liu, Xiaoyi Wang, Makoto Ikeya · 2022 · Japanese Dental Science Review
  54. Modeling Movement Disorders via Generation of hiPSC-Derived Motor Neurons
    Masuma Akter, Baojin Ding · 2022 · Cells
  55. A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction
    Yu‐Shan Cheng, Miao Xu, Guibin Chen, Jeanette K. Beers, Catherine Z. Chen, Chengyu Liu, Jizhong Zou, Wei Zheng · 2023 · Current Protocols
  56. Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations
    Chao Chen, Min‐Xin Guan · 2023 · Journal of Biomedical Science
  57. Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases
    Lizhao Feng, Jianfei Chao, Mingzi Zhang, Elizabeth Pacquing, Weidong Hu, Yanhong Shi · 2023 · iScience
  58. Unlocking the therapeutic potential: odyssey of induced pluripotent stem cells in precision cell therapies
    Popat B Mohite, Abhijeet Vishnu Puri, Roshan Dave, Aarati Budar, Shubham V. Munde, Shruti Bagchi Ghosh, Taha Alqahtani, Humood Al Shmrany, Ajoy Kumer, Bikram Dhara · 2024 · International Journal of Surgery
  59. Deploying human pluripotent stem cells to treat central nervous system disorders: facts, challenges and realising the potential
    Timothy E. Allsopp, Andreas Ebneth, Alfredo Cabrera‐Socorro · 2019 · Stem Cell Research
  60. Replicates in stem cell models—How complicated!
    J. C. W. Chan, Adrian Kee Keong Teo · 2020 · Stem Cells
  61. Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models
    Ying Zhang, Xinyang Xie, Jiangnan Hu, Kazi Sabrina Afreen, Chun‐Li Zhang, Qichuan Zhuge, Jianjing Yang · 2020 · Frontiers in Neuroscience
  62. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing
    Mirella Ejiugwo, Yury A. Rochev, Georgina Gethin, Gerard M. O’Connor · 2021 · Tissue Engineering Part C Methods
  63. Bringing Induced Pluripotent Stem Cell Technology to the Bedside
    Peter Karagiannis, Ayaka Nakauchi, Shinya Yamanaka · 2018 · JMA Journal
  64. CRISPRi/a Screening with Human iPSCs
    Masataka Nishiga, Lei S. Qi, Joseph C. Wu · 2021 · Methods in molecular biology
  65. Conditional reprogramming: Modeling urological cancer and translation to clinics
    Wei Liu, Lingao Ju, Songtao Cheng, Gang Wang, Kaiyu Qian, Xuefeng Liu, Yu Xiao, Xinghuan Wang · 2020 · Clinical and Translational Medicine
  66. Current and Future Cornea Chip Models for Advancing Ophthalmic Research and Therapeutics
    Min-Ju Kim, Kanghoon Choi, Amy Lin, Jungkyu Kim · 2025 · Advanced Biology
  67. Derivation of endothelial cells from porcine induced pluripotent stem cells by optimized single layer culture system
    Renyue Wei, Jiawei Lv, Xuechun Li, Yan Li, Qianqian Xu, Jun‐Xue Jin, Yu Zhang, Z.H. Liu · 2019 · Journal of Veterinary Science
  68. Thyroid hormones regulate cardiac repolarization and QT-interval related gene expression in hiPSC cardiomyocytes
    Alessandra Ulivieri, Luca Lavra, Fiorenza Magi, Alessandra Morgante, Leonardo Calò, Patrizio Polisca, Leila Baghernajad Salehi, Salvatore Sciacchitano · 2022 · Scientific Reports
  69. Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models
    María Pelechá-Salvador, Estela Villanueva-Bádenas, Enrique Timor-López, María Teresa Donato, Laia Tolosa · 2021 · Antioxidants
  70. In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening
    Huyen Thi Ngo, Sarnai Amartumur, Van Thi Ai Tran, Minh Tran, Yen Ngoc Diep, Hansang Cho, Luke P. Lee · 2023 · Biosensors
  71. Complexity‐to‐Diversity and Pseudo‐Natural Product Strategies as Powerful Platforms for Deciphering Next‐Generation Therapeutics
    Bilal O. Alkubaisi, Afnan I. Shahin, Ruba A. Zenati, Anil Ravi, Riema Alchami, Mohammad Alkalla, Rawan Khaled, Mohammed Ibrahim El-Gamal, Taleb H. Al‐Tel · 2023 · ChemMedChem
  72. Current overview of induced pluripotent stem cell-based blood-brain barrier-on-a-chip
    Arielly H. Alves, Mariana Penteado Nucci, Nicole M. E. Valle, Juliana Morais Missina, Javier Bustamante Mamani, Gabriel N. A. Rego, Olívia Furiama Metropolo Dias, Murilo Montenegro Garrigós, Fernando A. Oliveira, Lionel Fernel Gamarra · 2023 · World Journal of Stem Cells
  73. Accelerating Diverse Cell-Based Therapies Through Scalable Design
    Emma L. Peterman, Deon S. Ploessl, Kate E. Galloway · 2024 · Annual Review of Chemical and Biomolecular Engineering
  74. Stem Cells and Acellular Preparations in Bone Regeneration/Fracture Healing: Current Therapies and Future Directions
    Marcel G. Brown, Davis J. Brady, Kelsey M. Healy, Kaitlin A. Henry, Ayobami S. Ogunsola, Xue Ma · 2024 · Cells
  75. Highly efficient scarless knock-in of reporter genes into human and mouse pluripotent stem cells via transient antibiotic selection
    Valentin M. Sluch, Xitiz Chamling, Claire Wenger, Yukan Duan, Dennis S. Rice, Donald J. Zack · 2018 · PLoS ONE
  76. Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension
    Vincent Yeung, Gareth R. Willis, Elizabeth S. Taglauer, S. Alex Mitsialis, Stella Kourembanas · 2019 · Springer eBooks
  77. Building a Human Brain for Research
    Mainá Bitar, Guy Barry · 2020 · Frontiers in Molecular Neuroscience
  78. Fluorescent indicators for continuous and lineage‐specific reporting of cell‐cycle phases in human pluripotent stem cells
    Yun Chang, Peter B. Hellwarth, Lauren N. Randolph, Yufei Sun, Yuxian Xing, Wuqiang Zhu, Xiaojun Lance Lian, Xiaoping Bao · 2020 · Biotechnology and Bioengineering
  79. State-of-the-Art Technology of Model Organisms for Current Human Medicine
    Masamitsu Konno, Ayumu Asai, Toru Kitagawa, Masami Yabumoto, Ken Ofusa, Takahiro Arai, Takaaki Hirotsu, Yuichiro� Doki, Hidetoshi Eguchi, Hideshi Ishii · 2020 · Diagnostics
  80. Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review
    Ruth Monk, Bronwen J. Connor · 2021 · Cells
  81. Induced Pluripotent Stem Cells for Inherited Optic Neuropathies—Disease Modeling and Therapeutic Development
    Joshua Paul Harvey, Paul E. Sladen, Patrick Yu‐Wai‐Man, Michael E. Cheetham · 2021 · Journal of Neuro-Ophthalmology
  82. Lupus Heart Disease Modeling with Combination of Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Lupus Patient Serum
    Narae Park, Yeri Alice Rim, Hyerin Jung, Yoojun Nam, Ji Hyeon Ju · 2021 · International Journal of Stem Cells
  83. Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
    Maria R Pozo, Gantt W. Meredith, Emilia G. Entcheva · 2022 · Cells
  84. Human In Vitro Models of Epilepsy Using Embryonic and Induced Pluripotent Stem Cells
    Muhammad Shahid Javaid, Tracie Tan, Naomi Dvir, Alison Anderson, Terence John O'Brien, Patrick Kwan, Ana Antonic‐Baker · 2022 · Cells
  85. CrisPR/CRIS systems are highly effective and useful for genomic manipulation. Despite this, cardiac treatment remains difficult due to existing genome editing and delivery processes.
    Moataz Dowaidar · 2021
  86. Musculoskeletal organoids: An emerging toolkit for establishing personalized models of musculoskeletal disorders and developing regenerative therapies
    Yuwei Liu, Zhilong Zhou, Gang Lu, Xin Zhang, Dongquan Shi, Liping Tong, Chang Chen, Rocky S. Tuan, Zhong Alan Li · 2025 · Acta Biomaterialia
  87. Self-assembling proteins as high-performance substrates for embryonic stem cell self-renewal
    Hill, Christopher J., Fleming, Jennifer R., Mousavinejad, Masoumeh, Nicholson, Rachael, Tzokov, Svetomir B., Bullough, Per A., Bogomolovas, Julius, Morgan, Mark R., Mayans, Olga, Murray, Patricia · 2019 · Advanced Materials
  88. Modeling MyD88 Deficiency In Vitro Provides New Insights in Its Function
    Nils Craig-Mueller, Ruba Hammad, Roland Elling, Jamal Alzubi, Barbara Timm, Julia Kolter, Nele Knelangen, Christien Bednarski, Birgitta Gläser, Sandra Ammann et al. · 2020 · Frontiers in Immunology
  89. Microfluidics as efficient technology for the isolation and characterization of stem cells
    Aghlmandi, Afsoon, Nikshad, Aylin, Safaralizadeh, Reza, Majid Ebrahimi Warkiani, Aghebati-Maleki, Leili, Yousefi, Mehdi · 2020 · PubMed Central
  90. Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage
    Heather Branscome, Pooja Khatkar, Sarah Al Sharif, Dezhong Yin, Sheela Jacob, Maria Cowen, Yuriy Kim, James W. Erickson, Christine A. Brantner, Nazira El‐Hage et al. · 2022 · Scientific Reports
  91. Tracking connectivity maps in human stem cell–derived neuronal networks by holographic optogenetics
    Felix Schmieder, Rouhollah Habibey, Johannes Striebel, Lars Büttner, Jürgen W. Czarske, Volker Busskamp · 2022 · Life Science Alliance
  92. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
    Jeffrey J. Kim, Etienne W. Daadi, Thomas T Oh, Elyas S. Daadi, Marcel M. Daadi · 2022 · Genes
  93. Aligned multi-walled carbon nanotube-embodied hydrogel via low magnetic field: A strategy for engineering aligned injectable scaffolds
    Muthusamy Saranya, Janne Tapio Koivisto, Ana C.M. Carvalho, F. Sato, Andrea Lassenberger, Lionel Porcar, Baleeswaraiah Muchharla, Saikat Talapatra, Birgitte Hjelmeland McDonagh, Lauriane Janssen et al. · 2022 · Composites Part B Engineering
  94. Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants
    Alessandra Granata · 2023 · BMC Cardiovascular Disorders
  95. Toward the use of novel alternative methods in epilepsy modeling and drug discovery
    Claudia Miguel Sanz, Miriam Martinez Navarro, Daniel Caballero Diaz, Gentzane Sánchez‐Elexpuru, Vincenzo Di Donato · 2023 · Frontiers in Neurology
  96. Transcriptional Dysregulation and Impaired Neuronal Activity in FMR1 Knock-Out and Fragile X Patients’ iPSC-Derived Models
    Gilles Maussion, Cecilia Rocha, Narges Abdian, Dimitri Yang, J Turk, Dulce Carrillo Valenzuela, Luisa S.B. Pimentel, Zhipeng You, Barbara Morquette, Michaël Nicouleau et al. · 2023 · International Journal of Molecular Sciences
  97. Nanomedicines to treat rare neurological disorders: The case of Krabbe disease
    Thomas L. Moore, Giovanna Pannuzzo, Gabriella Costabile, Anna Lisa Palange, Raffaele Spanò, Miguel Filipe Moreira Marques Ferreira, Adriana Carol Eleonora Graziano, Paolo Decuzzi, Venera Cardile · 2023 · Advanced Drug Delivery Reviews
  98. Microscale tissue engineering of liver lobule models: advancements and applications
    Qi Wang, Juan Liu, Wenzhen Yin, Anqi Wang, Jingjing Zheng, Yunfang Wang, Jiahong Dong · 2023 · Frontiers in Bioengineering and Biotechnology
  99. A logic-incorporated gene regulatory network deciphers principles in cell fate decisions
    Gang Xue, Xiaoyi Zhang, Wanqi Li, Lu Zhang, Zongxu Zhang, Xiaolin Zhou, Di Zhang, Lei Zhang, Zhiyuan Li · 2024 · eLife
  100. Impaired proteostasis in rare neurological diseases
    Nerea Osinalde, Anna Duarri, Juanma Ramírez, Rosa Barrio, Guiomar Pérez de Nanclares, Ugo Mayor · 2018 · Seminars in Cell and Developmental Biology